// STATE LEGISLATION TRACKER

Minnesota HF 2755: Labor and industry finance bill.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Minnesota
Bill: HF 2755
Filed: 2023-03-09
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Minnesota HF2755 is a labor and industry finance bill, not a health care, pharmacy, compounding, telehealth, or prescribing bill. Based on the title and available bill description, it does not appear to change peptide access, clinician prescribing, FDA 503A/503B compounding, controlled substances rules, or prescription monitoring.

Key Points

No apparent change to compounded peptide access in Minnesota.
No apparent change to off-label prescribing rules.
No apparent change to NP or naturopathic prescribing scope.
No apparent change to telehealth peptide prescribing.
No apparent change to PMP or controlled-substance peptide rules.

What to Watch For

Note Because this is a broad finance bill, check any later amendments before relying on it for health policy conclusions.

Note Peptide users should watch separate pharmacy, medical board, telehealth, or controlled-substance bills instead.

Where the Bill Stands

HF2755 advanced to committee in the 2023-2024 session but did not become law before that session ended.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws